niacinamide has been researched along with Acne in 29 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5-1 mg/kg/day for papulo-pustular or nodulo-cystic acne were randomized to additionally receive a cream composed of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide applied twice daily (group A) or placebo cream (group B) applied 2 times per day." | 9.27 | Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients. ( Bianchi, L; Cannizzaro, MV; Dattola, A; Del Duca, E; Garofalo, V, 2018) |
| "Nicotinamide and clindamycin gels are two popular topical medications for acne vulgaris." | 9.17 | Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris. ( Amirnia, M; Fouladi, RF; Karimi, ER; Khodaeiani, E; Saeidi, M, 2013) |
| "In our double-blind investigation, the safety and efficacy of topically applied 4% nicotinamide gel was compared to 1% clindamycin gel for the treatment of moderate inflammatory acne vulgaris." | 9.08 | Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. ( Chalker, DK; Parish, LC; Shalita, AR; Smith, JG; Sofman, MS, 1995) |
| "To assess the effects of topical treatments (azelaic acid, salicylic acid, nicotinamide, zinc, alpha-hydroxy acid, and sulphur) for acne." | 9.05 | Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. ( Liu, GJ; Liu, H; Liu, L; Peinemann, F; Sang, H; Xia, J; Yu, H, 2020) |
| "The effects of topical azelaic acid, salicylic acid, nicotinamide, sulfur, zinc, and fruit acid (alpha-hydroxy acid) for acne are unclear." | 9.05 | Evidence-based topical treatments (azelaic acid, salicylic acid, nicotinamide, sulfur, zinc, and fruit acid) for acne: an abridged version of a Cochrane systematic review. ( Liu, G; Liu, H; Liu, L; Peinemann, F; Sang, H; Xia, J; Yu, H, 2020) |
| "A multicenter prospective observational study was carried out on patients with a diagnosis of mild comedonal-papular facial acne to provide new evidence on the clinical effectiveness, tolerability and acceptability of three salicylic acid-based products for the topical treatment of acne in the daily clinical practice." | 7.96 | Effectiveness of a combination of salicylic acid-based products for the treatment of mild comedonal-papular acne: a multicenter prospective observational study. ( Bettoli, V; Micali, G; Monfrecola, G; Veraldi, S, 2020) |
| "Acne vulgaris is a chronic inflammatory skin disease that mostly develops during adolescence and continues throughout adulthood." | 6.94 | A retrospective assessment and comparison of the effectiveness of benzoyl peroxide; the combination of topical niacinamide, gallic acid, and lauric acid; and the combination of benzoyl peroxide and erythromycin in acne vulgaris. ( Akyol, M; Guner, RY; Kozan, A, 2020) |
| "Acne vulgaris is a common and chronic skin disease that impacts on physical and psychological perceptions." | 5.56 | Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary resul ( Annunziata, MC; Cinelli, E; Donnarumma, M; Fabbrocini, G; Milani, M; Villani, A, 2020) |
| "5-1 mg/kg/day for papulo-pustular or nodulo-cystic acne were randomized to additionally receive a cream composed of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide applied twice daily (group A) or placebo cream (group B) applied 2 times per day." | 5.27 | Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients. ( Bianchi, L; Cannizzaro, MV; Dattola, A; Del Duca, E; Garofalo, V, 2018) |
| "Nicotinamide and clindamycin gels are two popular topical medications for acne vulgaris." | 5.17 | Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris. ( Amirnia, M; Fouladi, RF; Karimi, ER; Khodaeiani, E; Saeidi, M, 2013) |
| "0001) number of patients demonstrated improvement over their previous acne treatment regimens after both 4 and 8 weeks of NicAzel (nicotinamide, azelaic acid, zinc, pyridoxine, copper, folic acid; Elorac Inc, Vernon Hills, IL) use." | 5.16 | Inflammatory acne management with a novel prescription dietary supplement. ( Akhavan, A; Day, D; Falcon, R; Iannotta, P; Janiga, A; Kallal, JE; Olansky, A; Shalita, AR; Singri, P, 2012) |
| "This study evaluated the efficacy and tolerability of treating mild-to-moderate facial acne using a new, hand-held, light-emitting diode blue light device in conjunction with a foam cleanser containing 5% glycolic acid and 2% salicylic acid plus a skin rebuilding serum containing 1." | 5.15 | Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system. ( Dhawan, S; Wheeland, RG, 2011) |
| "In our double-blind investigation, the safety and efficacy of topically applied 4% nicotinamide gel was compared to 1% clindamycin gel for the treatment of moderate inflammatory acne vulgaris." | 5.08 | Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. ( Chalker, DK; Parish, LC; Shalita, AR; Smith, JG; Sofman, MS, 1995) |
| "To assess the effects of topical treatments (azelaic acid, salicylic acid, nicotinamide, zinc, alpha-hydroxy acid, and sulphur) for acne." | 5.05 | Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. ( Liu, GJ; Liu, H; Liu, L; Peinemann, F; Sang, H; Xia, J; Yu, H, 2020) |
| "The effects of topical azelaic acid, salicylic acid, nicotinamide, sulfur, zinc, and fruit acid (alpha-hydroxy acid) for acne are unclear." | 5.05 | Evidence-based topical treatments (azelaic acid, salicylic acid, nicotinamide, sulfur, zinc, and fruit acid) for acne: an abridged version of a Cochrane systematic review. ( Liu, G; Liu, H; Liu, L; Peinemann, F; Sang, H; Xia, J; Yu, H, 2020) |
| "Nicotinamide (niacinamide), a physiologically active form of niacin (nicotinic acid), in combination with zinc is being assessed in clinical studies for the treatment of inflammatory skin diseases such as acne vulgaris and bullous pemphigoid." | 4.83 | The mechanisms of action of nicotinamide and zinc in inflammatory skin disease. ( Fivenson, DP, 2006) |
| "A multicenter prospective observational study was carried out on patients with a diagnosis of mild comedonal-papular facial acne to provide new evidence on the clinical effectiveness, tolerability and acceptability of three salicylic acid-based products for the topical treatment of acne in the daily clinical practice." | 3.96 | Effectiveness of a combination of salicylic acid-based products for the treatment of mild comedonal-papular acne: a multicenter prospective observational study. ( Bettoli, V; Micali, G; Monfrecola, G; Veraldi, S, 2020) |
| "Niacinamide has been verified in treating almost every skin disorder, viz." | 2.72 | Cosmeceutical Aptitudes of Niacinamide: A Review. ( Madaan, P; Malik, DS; Sikka, P, 2021) |
| "Acne and rosacea are common inflammatory processes historically classified in the same disease category, but evolving understanding of their disparate pathophysiology and exacerbating factors have generated an enormous armamentarium of therapeutic possibilities." | 2.53 | Over-the-counter treatments for acne and rosacea. ( Rosamilia, LL, 2016) |
| "The use of topical nicotinamide in the treatment of acne vulgaris; melasma; atopic dermatitis; rosacea; and oral nicotinamide in preventing nonmelanoma skin cancer is discussed." | 2.50 | A review of nicotinamide: treatment of skin diseases and potential side effects. ( Rolfe, HM, 2014) |
| " However, long-term use of these agents has drawbacks: steroids may induce numerous serious side effects such as hypertension, immunosuppression, and osteoporosis, and overuse of oral antibiotics may contribute to the development of bacterial resistance, as well as to a host of nuisance side effects such as diarrhea, yeast infections, and photosensitivity." | 2.43 | Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review. ( Niren, NM, 2006) |
| "Acne vulgaris is a common and chronic skin disease that impacts on physical and psychological perceptions." | 1.56 | Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary resul ( Annunziata, MC; Cinelli, E; Donnarumma, M; Fabbrocini, G; Milani, M; Villani, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.45) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 15 (51.72) | 24.3611 |
| 2020's | 9 (31.03) | 2.80 |
| Authors | Studies |
|---|---|
| Madaan, P | 1 |
| Sikka, P | 1 |
| Malik, DS | 1 |
| Li, W | 1 |
| Yu, Q | 1 |
| Shen, Z | 1 |
| Zhang, L | 1 |
| Zhang, W | 1 |
| Li, C | 1 |
| Santos-Caetano, JP | 1 |
| Gfeller, CF | 1 |
| Mahalingam, H | 1 |
| Thompson, M | 1 |
| Moore, DJ | 1 |
| Vila, R | 1 |
| Doi, R | 1 |
| Cargill, MR | 1 |
| Abd-Allah, H | 1 |
| Abdel-Aziz, RTA | 2 |
| Nasr, M | 2 |
| Liu, H | 2 |
| Yu, H | 2 |
| Xia, J | 2 |
| Liu, L | 2 |
| Liu, GJ | 1 |
| Sang, H | 2 |
| Peinemann, F | 2 |
| Kozan, A | 1 |
| Guner, RY | 1 |
| Akyol, M | 1 |
| Villani, A | 1 |
| Annunziata, MC | 1 |
| Cinelli, E | 1 |
| Donnarumma, M | 1 |
| Milani, M | 1 |
| Fabbrocini, G | 1 |
| Liu, G | 1 |
| Bettoli, V | 2 |
| Micali, G | 1 |
| Monfrecola, G | 1 |
| Veraldi, S | 2 |
| Ibrahim, F | 1 |
| El-Deen, AK | 1 |
| El Abass, SA | 1 |
| Shimizu, K | 1 |
| Cannizzaro, MV | 1 |
| Dattola, A | 1 |
| Garofalo, V | 1 |
| Del Duca, E | 1 |
| Bianchi, L | 1 |
| Karandikar, H | 1 |
| Moftah, N | 1 |
| Paradkar, A | 1 |
| Khodaeiani, E | 1 |
| Fouladi, RF | 1 |
| Amirnia, M | 1 |
| Saeidi, M | 1 |
| Karimi, ER | 1 |
| Chen, AC | 1 |
| Damian, DL | 1 |
| Rolfe, HM | 1 |
| Rosamilia, LL | 1 |
| Forbat, E | 1 |
| Al-Niaimi, F | 1 |
| Ali, FR | 1 |
| Barros, BS | 1 |
| Zaenglein, AL | 1 |
| Walocko, FM | 1 |
| Eber, AE | 1 |
| Keri, JE | 1 |
| Al-Harbi, MA | 1 |
| Nouri, K | 1 |
| Saint-Jean, M | 1 |
| Khammari, A | 1 |
| Seite, S | 1 |
| Moyal, D | 1 |
| Dreno, B | 1 |
| Wheeland, RG | 1 |
| Dhawan, S | 1 |
| Morganti, P | 1 |
| Berardesca, E | 1 |
| Guarneri, B | 1 |
| Guarneri, F | 1 |
| Fabrizi, G | 1 |
| Palombo, P | 1 |
| Palombo, M | 1 |
| Giovene, GL | 1 |
| Guerriero, C | 1 |
| Shalita, AR | 2 |
| Falcon, R | 1 |
| Olansky, A | 1 |
| Iannotta, P | 1 |
| Akhavan, A | 1 |
| Day, D | 1 |
| Janiga, A | 1 |
| Singri, P | 1 |
| Kallal, JE | 1 |
| Niren, NM | 2 |
| Fivenson, DP | 1 |
| Torok, HM | 1 |
| Smith, JG | 1 |
| Parish, LC | 1 |
| Sofman, MS | 1 |
| Chalker, DK | 1 |
| Jablonska, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Parallel-group, Evaluator-blind, No-treatment and Positive Controlled, Single-site, Proof of Concept Clinical Study to Evaluate the Cosmetic Benefit Provided by 8 Weeks of Twice-daily Topical Application of a Developmental Moisturizing Cream[NCT03093181] | 157 participants (Actual) | Interventional | 2017-04-04 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
A blinded, trained and qualified evaluator conducted instrumental measurements of skin moisturization.Measurement of skin moisturization was performed by the electrical capacitance method with a Corneometer CM 865. The measuring principle was based on changes in the capacitance of the measuring head, functioning as a condensator. Between the conductors of the probe an electrical field was built which allows the dielectricity of the stratum corneum to be measured. Because the dielectricity of the skin varies as a function of its water content.The range of hydration level was 0 (as dry as possible)~120 AU (Arbitrary Unit)(most moist possible).Higher Corneometer values are indicative of improved skin moisturization. (NCT03093181)
Timeframe: At Baseline and Day 1
| Intervention | Arbitrary Corneometer unit (Mean) |
|---|---|
| Test Product Regimen | 6.14 |
| No Treatment Regimen | 2.63 |
| Positive Control Regimen | 3.60 |
Baseline and Week 8 photographs of all participants were displayed side by side on high resolution, color-calibrated display screen in room with neutral wall colors and standardized lighting with minimized glare. Relative positioning (left and right) of baseline and Week 8 photographs were blinded to evaluator and randomized. Lay evaluators ranked magnitude of improvement in overall appearance of blemishes using below criteria: Left=blemishes on left are more obvious than those on right; Right=blemishes on right are more obvious than those on left. Lay evaluator ranking for each image pair was converted into a numerical score based on whether Baseline or Week 8 image was ranked better:0=Baseline image was better than Week 8 image,1=Week 8 image was better than Baseline image. Minimum score 0 corresponded to all baseline images being better than Week 8 images. Maximum score 1 corresponded to all Week 8 images being better than baseline images. Higher scores indicated better results. (NCT03093181)
Timeframe: At Baseline and Week 8
| Intervention | Score on scale (Least Squares Mean) | |
|---|---|---|
| For Polarised Image | For Non-polarised Image | |
| No Treatment Regimen | 0.50 | 0.52 |
| Positive Control Regimen | 0.51 | 0.51 |
| Test Product Regimen | 0.65 | 0.67 |
A blinded, trained and qualified evaluator conducted instrumental measurements of skin moisturisation. Measurement of skin moisturisation was performed by the electrical capacitance method with a Corneometer CM 865. The measuring principle was based on changes in the capacitance of the measuring head, functioning as a condensator. Between the conductors of the probe an electrical field was built which allows the dielectricity of the stratum corneum to be measured. Because the dielectricity of the skin varies as a function of its water content. Higher Corneometer values are indicative of improved skin moisturisation. (NCT03093181)
Timeframe: At Baseline, Day 1, Week 1, 4 and 8
| Intervention | Arbitrary Corneometer unit (Mean) | ||||
|---|---|---|---|---|---|
| At 1 hour, Day 1 | At 3 hour, Day 1 | At Week 1 | At Week 4 | At Week 8 | |
| No Treatment Regimen | -3.69 | 0.68 | 0.06 | 3.16 | 3.32 |
| Positive Control Regimen | 4.55 | 4.33 | 3.31 | 1.04 | 2.51 |
| Test Product Regimen | 11.52 | 9.64 | 4.39 | 4.33 | 7.54 |
A treatment blind, trained and qualified evaluator counted the total number of facial blemishes on the forehead, cheeks and chin of the participants. (NCT03093181)
Timeframe: At Baseline, Week 1, 4 and 8
| Intervention | Total Blemish Count (Mean) | ||
|---|---|---|---|
| At Week 1 | At Week 4 | At Week 8 | |
| No Treatment Regimen | -1.05 | -2.76 | -3.79 |
| Positive Control Regimen | -0.93 | -4.00 | -5.12 |
| Test Product Regimen | -0.70 | -3.86 | -5.68 |
The forehead of each participant was thoroughly cleansed by the investigator or designee using cotton pads saturated with 70% Isopropyl Alcohol and, after 5 minutes, the central area of the forehead above the eyebrows was measured in triplicate with a Sebumeter. The same area was measured in triplicate 90 minutes after cleansing. The sebum excretion rate was calculated by the difference in 90th minutes and 5th minute Sebumeter values. (NCT03093181)
Timeframe: At Baseline, Week 1, 4 and 8
| Intervention | μg/cm^2 (Mean) | ||
|---|---|---|---|
| At Week 1 | At Week 4 | At Week 8 | |
| No Treatment Regimen | 38.72 | 44.97 | 32.91 |
| Positive Control Regimen | 66.73 | 53.17 | 67.10 |
| Test Product Regimen | 20.36 | 30.49 | 38.04 |
A treatment blinded, trained and qualified evaluator conducted instrumental measurements of skin sebum levels. Measurement of skin sebum levels was performed by with a Sebumeter SM 815. The measurement principle of the SM 815 is based on grease spot photometry. The translucent tape of the device is brought into contact with skin and becomes increasingly transparent in response to surface oil. The tape is inserted into the aperture of the device and its transparency measured by light transmission, with increased transmission signifying increased oiliness. The software outputs mass sebum levels as a function of area. Sebumeter measurements were taken in triplicate at the central forehead (above the eyebrows) with the participant lying horizontally, on their back. (NCT03093181)
Timeframe: At Baseline, Week 1, 4 and 8
| Intervention | Micrograms (μg)/square centimeter (cm^2) (Mean) | ||
|---|---|---|---|
| At Week 1 | At Week 4 | At Week 8 | |
| No Treatment Regimen | -70.50 | -67.52 | -87.04 |
| Positive Control Regimen | -52.19 | -21.67 | -65.85 |
| Test Product Regimen | -54.98 | -49.57 | -86.49 |
The baseline and week 8 photographs of all participants were displayed side by side on high resolution, color-calibrated display screen in room with neutral wall colors and standardized lighting and all practical efforts were made to minimize glare. The relative positioning (left and right) of baseline and week 8 photographs were blinded to evaluator and randomized. A technician used randomization schedule to display pair of images to lay evaluator. Lay evaluators judged magnitude of improvement in overall appearance of blemishes using the below criteria: Left=blemishes on left are more obvious than those on the right and Right=blemishes on right are more obvious than those on the left. Layperson ranked both left and right image as follows:1=Better;2=Worse. Odds was calculated from logistic regression including treatment and age stratum effects and exchangeable correlation. Odds=p/(1-p) where p was the probability of event that Week 8 was better than baseline. (NCT03093181)
Timeframe: At Baseline and Week 8
| Intervention | Odds (Number) | |
|---|---|---|
| For Polarised Image | For Non-polarised Image | |
| No Treatment Regimen | 1.00 | 1.08 |
| Positive Control Regimen | 1.04 | 1.02 |
| Test Product Regimen | 1.84 | 2.06 |
11 reviews available for niacinamide and Acne
| Article | Year |
|---|---|
Cosmeceutical Aptitudes of Niacinamide: A Review.
Topics: Acne Vulgaris; Aptitude; Cosmeceuticals; Humans; Niacinamide; Skin Diseases | 2021 |
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Bias; Child; C | 2020 |
Evidence-based topical treatments (azelaic acid, salicylic acid, nicotinamide, sulfur, zinc, and fruit acid) for acne: an abridged version of a Cochrane systematic review.
Topics: Acne Vulgaris; Administration, Cutaneous; Dermatologic Agents; Dicarboxylic Acids; Fruit; Glycolates | 2020 |
Nicotinamide and the skin.
Topics: Acne Vulgaris; Animals; Autoimmune Diseases; Carcinogenesis; Dermatitis, Atopic; Humans; Keratosis, | 2014 |
A review of nicotinamide: treatment of skin diseases and potential side effects.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Chemical and Drug Induced Liver Inju | 2014 |
Over-the-counter treatments for acne and rosacea.
Topics: Acne Vulgaris; Administration, Cutaneous; Astringents; Benzoyl Peroxide; Dermatologic Agents; Deterg | 2016 |
Use of nicotinamide in dermatology.
Topics: Acne Vulgaris; Dermatitis, Atopic; Humans; Niacinamide; Pigmentation Disorders; Pruritus; Skin Disea | 2017 |
The Use of Cosmeceuticals in Acne: Help or Hoax?
Topics: Acne Vulgaris; Complementary Therapies; Contraindications; Cosmeceuticals; Deception; Glycolates; Hu | 2017 |
The role of nicotinamide in acne treatment.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Anti-Inflamma | 2017 |
Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review.
Topics: Acne Vulgaris; Anti-Inflammatory Agents; Drug Combinations; Humans; Immunoglobulin A; Niacinamide; R | 2006 |
The mechanisms of action of nicotinamide and zinc in inflammatory skin disease.
Topics: Acne Vulgaris; Anti-Inflammatory Agents; Drug Combinations; Humans; Lipogenesis; Molecular Structure | 2006 |
13 trials available for niacinamide and Acne
| Article | Year |
|---|---|
Efficacy and safety of a cream containing octyl salicylic acid, salicylic acid, linoleic acid, nicotinamide, and piroctone olamine combined with 5% benzoyl peroxide in the treatment of acne vulgaris: a randomized controlled study.
Topics: Acne Vulgaris; Benzoyl Peroxide; Drug Combinations; Ethanolamines; Gels; Humans; Linoleic Acid; Niac | 2022 |
Cosmetic benefits of a novel biomimetic lamellar formulation containing niacinamide in healthy females with oily, blemish-prone skin in a randomized proof-of-concept study.
Topics: Acne Vulgaris; Adolescent; Adult; Biomimetics; Cosmetics; Female; Humans; Middle Aged; Niacinamide; | 2020 |
A retrospective assessment and comparison of the effectiveness of benzoyl peroxide; the combination of topical niacinamide, gallic acid, and lauric acid; and the combination of benzoyl peroxide and erythromycin in acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Dermatologic Agents; Eryt | 2020 |
Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Ceramides; Dermat | 2018 |
Novel nicotinamide skin-adhesive hot melt extrudates for treatment of acne.
Topics: Acne Vulgaris; Adhesives; Adolescent; Adult; Animals; Drug Compounding; Female; Hot Temperature; Hum | 2018 |
Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Doubl | 2013 |
Characteristics of premenstrual acne flare-up and benefits of a dermocosmetic treatment: a double-blind randomised trial.
Topics: Acne Vulgaris; Adolescent; Adult; Cosmeceuticals; Double-Blind Method; Drug Combinations; Ethanolami | 2017 |
Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system.
Topics: Acne Vulgaris; Adult; Combined Modality Therapy; Dermatologic Agents; Dicarboxylic Acids; Drug Combi | 2011 |
Topical clindamycin 1% vs. linoleic acid-rich phosphatidylcholine and nicotinamide 4% in the treatment of acne: a multicentre-randomized trial.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Hum | 2011 |
Efficacy and tolerability of topical 0.2% Myrtacine® and 4% vitamin PP for prevention and treatment of retinoid dermatitis in patients with mild to moderate acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Child; Drug Com | 2012 |
Inflammatory acne management with a novel prescription dietary supplement.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Child; Copper; Dicarboxylic Acids; Dietary | 2012 |
The Nicomide Improvement in Clinical Outcomes Study (NICOS): results of an 8-week trial.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Inflammatory Agents; Child; Dose-Response Relationship, Drug; | 2006 |
Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Clindamycin; Dermatitis; Double-Blind Met | 1995 |
5 other studies available for niacinamide and Acne
| Article | Year |
|---|---|
Chitosan nanoparticles making their way to clinical practice: A feasibility study on their topical use for acne treatment.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Chitosan; Drug Carriers; Drug Stability; | 2020 |
Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary resul
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Infective Agents; Female; Gels; Glyc | 2020 |
Effectiveness of a combination of salicylic acid-based products for the treatment of mild comedonal-papular acne: a multicenter prospective observational study.
Topics: Acne Vulgaris; Adult; Carbamide Peroxide; Dermatologic Agents; Drug Combinations; Facial Dermatoses; | 2020 |
An ecofriendly green liquid chromatographic method for simultaneous determination of nicotinamide and clindamycin phosphate in pharmaceutical gel for acne treatment.
Topics: Acne Vulgaris; Chemistry, Pharmaceutical; Chromatography, Liquid; Clindamycin; Drug Stability; Hydro | 2017 |
Letter: Treatment of acne vulgaris and rosacea.
Topics: Acne Vulgaris; Administration, Topical; Ascorbic Acid; Humans; Niacinamide; Pyridoxine; Riboflavin; | 1975 |